Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRC101 in CKD and Metabolic Acidosis
NCT03317444Phase 3Completed
- Sponsor
- Tricida, Inc.
- Start
- Sep 2017
- Primary completion
- May 2018
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 8
01
Overview
A Phase 3 trial of veverimer in metabolic acidosis, sponsored by Tricida, Inc.. Started Sep 2017; status: completed.
02
Drugs
veverimer
03
Conditions
metabolic acidosis
Beyond the preview
Go deeper on NCT03317444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03317444.